riTUXimab:MCnc:Pt:Ser/Plas:Qn:IA

Preferred Label : riTUXimab:MCnc:Pt:Ser/Plas:Qn:IA;

LOINC status : ACTIVE;

LOINC display name : riTUXimab IA [Mass/Vol];

LOINC long common name : riTUXimab [Mass/volume] in Serum or Plasma by Immunoassay;

LOINC short name : riTUXimab SerPl IA-mCnc;

LOINC description : This serum rituximab drug level is intended for quantitative measurements of rituximab levels in human serum to aid in patient-specific therapeutic drug monitoring and dosing for individuals with non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL) and rheumatoid arthritis.;

Details

Origin ID

82467-2;

UMLS CUI

C4285514;

Has component
- riTUXimab [LOINC component]
Has method
- Immunoassay [LOINC method]
Has property
- Mass Concentration [LOINC Property]
Has system
- Plasma [LOINC System]
- Serum [LOINC System]
- Serum or Plasma [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients